A Placebo-Controlled Phase I Study of NVG-291 in Healthy Subjects, Targeting CNS Receptor Protein Tyrosine Phosphatase Sigma (PTPσ)

Category Primary study
JournalNeurology
Year 2022
This article has no abstract
Epistemonikos ID: bbe6243a67442818f806e2f1832f7bd254f63b6e
First added on: Feb 14, 2025